backJoin us for our second CLE webinar on the fundamentals of EU pharmaceutical law, in which we focus on the regulatory pathways for obtaining marketing authorizations in the EU.
Topics include:
• the two main procedures available in the EU: decentralized and centralized;
• expedited pathways, including conditional MAs and the early access system;
• various types of MA applications, providing insights for companies operating in or looking to expand their activities within Europe;
• analysis of potential changes under the proposed revision of the EU general pharmaceutical legislation.
Interested in upcoming sessions? Click here to be added to our mailing list. For information on upcoming sessions, email lifesciences@kslaw.com.